null

Anti-CD19 (Tafasitamab biosimilar) mAb (HDBS0730)

SKU:
HDBS0730
Antibody Type:
Biosimilar Reference Antibody
Applications:
Drug Development
Pharmacokinetics
Disease Area:
B-Cell Malignancies
Disease Area:
Immunotherapy
Size:
100 μg
Target:
CD19
Isotype:
IgG1
Host Species:
Whole mAb
Reactivity:
Human
€429

Description

system_update_altDatasheetsystem_update_altMSDS
Product Name:Anti-CD19 (Tafasitamab biosimilar) mAb
SKU:HDBS0730
Size:100 μg
Target:CD19
Common Name:ICP-B04;ICP B04;MOR 208;MOR208;MOR-208;XENP-5574;XENP5574;XENP 5574;XmAb-5574;XmAb5574;XmAb 5574
Isotype:IgG1
Host Species:Whole mAb
Reactivity:Human
Synonyms:CD19;B4;CVID3;MGC12802
Conjugate:Unconjugated

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Uniprot:P15391
Formulation & Reconstitution:Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Usage:Research use only
Storage & Shipping:Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Related Products